127 related articles for article (PubMed ID: 32569779)
21. TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability.
Zhou S; Peng J; Xiao L; Zhou C; Fang Y; Ou Q; Qin J; Liu M; Pan Z; Hou Z
Cell Death Dis; 2021 May; 12(5):463. PubMed ID: 33966039
[TBL] [Abstract][Full Text] [Related]
22. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
Yang C; Zhang Y; Lin S; Liu Y; Li W
Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
[TBL] [Abstract][Full Text] [Related]
23. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
[TBL] [Abstract][Full Text] [Related]
24. KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer.
Zheng Y; Wu J; Chen H; Lin D; Chen H; Zheng J; Xia H; Huang L; Zeng C
Cancer Biol Ther; 2023 Dec; 24(1):2226353. PubMed ID: 37431852
[TBL] [Abstract][Full Text] [Related]
25. Aberrant HMGA2 Expression Sustains Genome Instability That Promotes Metastasis and Therapeutic Resistance in Colorectal Cancer.
Campos Gudiño R; McManus KJ; Hombach-Klonisch S
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980621
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic role of adipose-derived mesenchymal stem cells-derived extracellular vesicles in rats with obstructive sleep apnea hypopnea syndrome.
Xu L; Zhang L; Xiang Y; Zhang X
Regen Ther; 2023 Mar; 22():210-223. PubMed ID: 36926469
[TBL] [Abstract][Full Text] [Related]
27. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.
Linares J; Sallent-Aragay A; Badia-Ramentol J; Recort-Bascuas A; Méndez A; Manero-Rupérez N; Re DL; Rivas EI; Guiu M; Zwick M; Iglesias M; Martinez-Ciarpaglini C; Tarazona N; Varese M; Hernando-Momblona X; Cañellas-Socias A; Orrillo M; Garrido M; Saoudi N; Elez E; Navarro P; Tabernero J; Gomis RR; Batlle E; Pisonero J; Cervantes A; Montagut C; Calon A
Nat Commun; 2023 Feb; 14(1):746. PubMed ID: 36765091
[TBL] [Abstract][Full Text] [Related]
28. Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy.
Mafi A; Rezaee M; Hedayati N; Hogan SD; Reiter RJ; Aarabi MH; Asemi Z
Cell Commun Signal; 2023 Feb; 21(1):33. PubMed ID: 36759799
[TBL] [Abstract][Full Text] [Related]
29. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer.
Huang CZ; Zhou Y; Tong QS; Duan QJ; Zhang Q; Du JZ; Yao XQ
Biomaterials; 2022 Nov; 290():121827. PubMed ID: 36228517
[TBL] [Abstract][Full Text] [Related]
30. CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer.
Hsieh CC; Hsu SH; Lin CY; Liaw HJ; Li TW; Jiang KY; Chiang NJ; Chen SH; Lin BW; Chen PC; Chan RH; Lin PC; Yeh YM; Shen CH
Br J Cancer; 2022 Nov; 127(9):1615-1628. PubMed ID: 35999268
[TBL] [Abstract][Full Text] [Related]
31. Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer.
Zhang Q; Deng T; Zhang H; Zuo D; Zhu Q; Bai M; Liu R; Ning T; Zhang L; Yu Z; Zhang H; Ba Y
Adv Sci (Weinh); 2022 Oct; 9(28):e2203357. PubMed ID: 35978266
[TBL] [Abstract][Full Text] [Related]
32. KLF5 inhibition overcomes oxaliplatin resistance in patient-derived colorectal cancer organoids by restoring apoptotic response.
Shen X; Zhang Y; Xu Z; Gao H; Feng W; Li W; Miao Y; Xu Z; Zong Y; Zhao J; Lu A
Cell Death Dis; 2022 Apr; 13(4):303. PubMed ID: 35379798
[TBL] [Abstract][Full Text] [Related]
33. Oxaliplatin-resistant colorectal cancer models for nanoparticle hyperthermia.
McCarthy B; Singh R; Levi-Polyachenko N
Int J Hyperthermia; 2021; 38(1):152-164. PubMed ID: 33576281
[TBL] [Abstract][Full Text] [Related]
34. The rediscovery of platinum-based cancer therapy.
Rottenberg S; Disler C; Perego P
Nat Rev Cancer; 2021 Jan; 21(1):37-50. PubMed ID: 33128031
[TBL] [Abstract][Full Text] [Related]
35. MT2A Promotes Oxaliplatin Resistance in Colorectal Cancer Cells.
Zhao Z; Zhang G; Li W
Cell Biochem Biophys; 2020 Dec; 78(4):475-482. PubMed ID: 32638210
[TBL] [Abstract][Full Text] [Related]
36. Identification of proteins regulated by chlorogenic acid in an ischemic animal model: a proteomic approach.
Shah MA; Kang JB; Koh PO
Lab Anim Res; 2023 Jun; 39(1):12. PubMed ID: 37271817
[TBL] [Abstract][Full Text] [Related]
37. Casein Kinase 2α Augments Oxaliplatin Resistance in Colorectal Cancer Cells by Increasing ABCE1 Expression.
Yun CW; Lee JH; Lee SH
Anticancer Res; 2023 Jun; 43(6):2519-2525. PubMed ID: 37247928
[TBL] [Abstract][Full Text] [Related]
38. Patient-derived xenograft models in cancer therapy: technologies and applications.
Liu Y; Wu W; Cai C; Zhang H; Shen H; Han Y
Signal Transduct Target Ther; 2023 Apr; 8(1):160. PubMed ID: 37045827
[TBL] [Abstract][Full Text] [Related]
39. Single-cell RNA analysis to identify five cytokines signaling in immune-related genes for melanoma survival prognosis.
Pu Z; Zhao Q; Chen J; Xie Y; Mou L; Zha X
Front Immunol; 2023; 14():1148130. PubMed ID: 37026000
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis.
Zheng Z; Wu M; Li H; Xu W; Yang M; Pan K; Ni Y; Jiang T; Zheng H; Jin X; Zhang Y; Ding L; Fu J
BMC Med; 2023 Apr; 21(1):132. PubMed ID: 37013584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
